Showing results (91-100 of 145) with videos related to
Sort By:
Pageof 15
Asia-Pacific Journal of Clinical Oncology|November 21, 2025
Clinical Need and Research Investment for Liver Cancer in AustraliaRomario Nguyen, Fatema Safri, Ankur Sharma, et al.Clinical and Molecular Hepatology|April 16, 2024
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysisHarry Crane, Guy D Eslick, Cameron Gofton, et al.Journal of Gastroenterology and Hepatology|October 24, 2024
Cirrhosis in primary practice: many patients remain potentially undiagnosed and are not receiving liver cancer surveillanceDavid S Prince, Shakira Hoque, Christy Kim, et al.Hepatology Communications|June 27, 2024
Screening patients in general practice for advanced chronic liver disease using an innovative IT solution: The Liver ToolkitDavid S Prince, Shakira Hoque, Christy Kim, et al.Cancers|June 10, 2022
Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0Savio G Barreto, Simone I Strasser, Geoffrey W McCaughan, et al.Journal of Gastroenterology and Hepatology|April 25, 2023
Epidemiology, characteristics, and outcomes of patients with acute-on-chronic liver failure in AustraliaJohn David Chetwood, Abdul-Hamid Sabih, Karen Chan, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 7, 2012
Analysis of human liver disease using a cluster of differentiation (CD) antibody microarrayWassim Rahman, Pauline Huang, Larissa Belov, et al.Transplantation|November 17, 2025
Cirrhotic Cardiomyopathy Predicts New-onset Heart Failure Within the First Year After Liver TransplantationMadeleine Gill, Christian Abhayaratna, Daniel Brieger, et al.Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.Drug and Alcohol Review|August 2, 2024
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)Paul J Clark, Patricia C Valery, Simone I Strasser, et al.Pageof 15